Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Change in Account Payables: 2011-2024

Historic Change in Account Payables for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to -$1.4 million.

  • Mimedx Group's Change in Account Payables rose 378.76% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 314.88%. This contributed to the annual value of -$1.4 million for FY2024, which is 280.08% down from last year.
  • Per Mimedx Group's latest filing, its Change in Account Payables stood at -$1.4 million for FY2024, which was down 280.08% from $783,000 recorded in FY2023.
  • Over the past 5 years, Mimedx Group's Change in Account Payables peaked at $839,000 during FY2022, and registered a low of -$1.4 million during FY2024.
  • For the 3-year period, Mimedx Group's Change in Account Payables averaged around $70,667, with its median value being $783,000 (2023).
  • In the last 5 years, Mimedx Group's Change in Account Payables surged by 627.67% in 2022 and then slumped by 280.08% in 2024.
  • Yearly analysis of 5 years shows Mimedx Group's Change in Account Payables stood at $177,000 in 2020, then plummeted by 189.83% to -$159,000 in 2021, then soared by 627.67% to $839,000 in 2022, then declined by 6.67% to $783,000 in 2023, then crashed by 280.08% to -$1.4 million in 2024.